jnccn.org/abstract/journals/jnccn/16/1/article-p11.xml
Preview meta tags from the jnccn.org website.
Linked Hostnames
14- 140 links tojnccn.org
- 101 links toscholar.google.com
- 69 links topubmed.ncbi.nlm.nih.gov
- 32 links towww.ncbi.nlm.nih.gov
- 2 links towww.nccn.org
- 1 link todoi.org
- 1 link toeducation.nccn.org
- 1 link tojnccn360.org
Thumbnail
Search Engine Appearance
https://jnccn.org/abstract/journals/jnccn/16/1/article-p11.xml
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
Bing
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
https://jnccn.org/abstract/journals/jnccn/16/1/article-p11.xml
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
DuckDuckGo
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
General Meta Tags
83- titleNCCN Guidelines Insights: Multiple Myeloma, Version 3.2018 in: Journal of the National Comprehensive Cancer Network Volume 16 Issue 1 (2018)
- Content-Typetext/html; charset=utf-8
- descriptionThe NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
- article:authorShaji K. Kumar
- article:authorNatalie S. Callander
Open Graph Meta Tags
7- og:urlhttps://jnccn.org/view/journals/jnccn/16/1/article-p11.xml
- og:site_nameJNCCN
- og:typearticle
- og:titleNCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
- og:descriptionThe NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:site@jnccn
- twitter:titleNCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
- twitter:descriptionThe NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.
Link Tags
15- alternate/newsrss
- canonicalhttps://jnccn.org/view/journals/jnccn/16/1/article-p11.xml
- dns-prefetch//ajax.googleapis.com
- preconnect//ajax.googleapis.com
- preconnect//ajax.googleapis.com
Emails
2- [email protected]
- ?subject=Link%20to%20NCCN%20Guidelines%20Insights%3A%20Multiple%20Myeloma%2C%20Version%203.2018&body=https%3A%2F%2Fjnccn.org%2Fview%2Fjournals%2Fjnccn%2F16%2F1%2Farticle-p11.xml
Links
353- http://education.nccn.org/node/82370
- http://scholar.google.com/scholar_lookup?title=A+phase+I%2FII+study+of+ixazomib+%28Ix%29+pomalidomide+%28POM%29+dexamethasone+%28DEX%29+in+relapsed+refractory+%28R%2FR%29+multiple+myeloma%3A+initial+results+%5Babstract%5D&author=AY+P+J+Krishnan+Kapoor+Palmer&publication_year=2016&journal=J+Clin+Oncol&volume=34&issue=Suppl+15
- http://scholar.google.com/scholar_lookup?title=A+randomized+phase+III+trial+of+lenalidomide+pus+high-dose+dexamethasone+versus+lenalidomide+plus+low-dose+dexamethasone+in+newly+diagnosed+multiple+myeloma+%28E4A03%29%3A+a+trial+coordinated+by+the+Eastern+Cooperative+Oncology+Group+%5Babstract%5D&author=SV+S+N+Rajkumar+Jacobus+Callander&publication_year=2006&journal=Blood&volume=108
- http://scholar.google.com/scholar_lookup?title=Alliance+A061202%2C+a+phase+I%2FII+study+of+pomalidomide%2C+dexamethasone+and+ixazomib+versus+pomalidomide+and+dexamethasone+for+patients+with+multiple+myeloma+refractory+to+lenalidomide+and+proteasome+inhibitor+based+therapy%3A+phase+I+results+%5Babstract%5D&author=PM+F+H+Voorhees+Mulkey+Hassoun&publication_year=2015&conference=Presented+at+the+57th+Annual+ASH+Meeting
- http://scholar.google.com/scholar_lookup?title=Bortezomib+consolidation+after+autologous+stem+cell+transplantation+in+multiple+myeloma%3A+a+Nordic+Myeloma+Study+Group+randomized+phase+3+trial&author=UH+P+O+Mellqvist+Gimsing+Hjertner&publication_year=2013&journal=Blood&volume=121&pages=4647-4654